Replimune Group (REPL) news
Recent news
Replimune Group, Inc. files for mixed shelf; size not disclosed - SEC filing
Replimune Group, Inc. (Nasdaq: REPL) has filed a new shelf registration statement with the U.S. Securities and Exchange Commission (SEC), which allows the company to offer and sell securities from time to time in the future without disclosing the specific size of the offering in the filing. Shelf…
AInvest Wire · Aug 14, 2026Replimune prices offer of 9.7M shares at $12.06/shr
Replimune Group Inc. has announced the pricing of its underwritten public offering of 9.7 million shares at $12.06 per share [1]. The offering is part of the company’s ongoing efforts to raise capital to support its research and development initiatives. The shares are being offered by the company…
AInvest Wire · Aug 10, 2026Replimune announces pricing of $150M underwritten offering
AInvest Wire · Aug 10, 2026Replimune Group offers 2.7 mln pre-funded warrants at $12.06 per warrant
Replimune Group, Inc. (Nasdaq: REPL) has announced the issuance of 2.7 million pre-funded warrants at a price of $12.06 per warrant as part of a recent public offering. The offering, which closed on November 27, 2024, included 6,923,000 shares of common stock and pre-funded warrants to purchase…
AInvest Wire · Aug 10, 2026Replimune Group prices offering of 9.7 mln shares at $12.06 per share
AInvest Wire · Aug 10, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.